Delivery Order SPE2DB24D1021-SPE2DB25FFAXL
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 10, 2025, for Veltassa 8.4 GM powder packets (30-count) with a ceiling value of $2,037.15 under firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,987.14 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of September 10, 2025. The award was issued on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $4,074.30 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veltassa 8.4 GM powder packets (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.79 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count) valued at $3,964.51. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,863.59 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Veltassa 8.4 GM Powder Packet in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and was awarded competitively without set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,424.40 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded transaction. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding agent used in the...
- The Defense Logistics Agency awarded a delivery order valued at $14,202.32 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime...
- The Defense Logistics Agency awarded a $5,636.48 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). The contract, classified as firm fixed price with no set-aside designation, is scheduled for ultimate completion by July 28, 2025. This delivery order is performed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAXLDelivery Order
The Defense Logistics Agency awarded a $2,716.20 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Veltassa 8.4 GM powder packets (quantity 30). This competitively awarded, firm fixed-price contract is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its substantial $999.99 billion IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. The current award for Veltassa, a potassium-binding medication used in treating hyperkalemia, exemplifies the company's role as a critical vendor for specialized pharmaceutical needs across Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/19/25 |